Intelligent Bio Solutions Inc. announced it has secured a major contract with one of London's largest public transport operators. This tender covers 14 operational sites in greater London and involves over 4,400 staff.
INBS's Intelligent Fingerprinting Drug Screening System will be deployed across a multi-garage bus network that carries over one million passengers daily, utilizing a fleet of more than 1,400 low-emission vehicles. This win highlights the strength of INBS's technology in supporting rapid drug testing at scale, minimizing operational disruption.
President and CEO Harry Simeonidis noted that the solution supports rapid drug testing at scale, meaning less people out of action for less time, which minimizes financial loss and improves overall workforce efficiency. The company's drug testing technology is adopted by over 450 accounts in 24 countries, with 18 distribution partners expanding its global reach.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.